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The present investigation, the first in the field, was aimed at analyzing differentially, on
individual samples, the effects of 55 days of horizontal bed rest, a model for microgravity, on
myosin heavy and myosin light chain isoforms distribution (by SDS) and on the proteome (by
2-D DIGE and MS) in the vastus lateralis (VL), a mixed type II/I (50:50%) head of the
quadriceps and in the calf soleus (SOL), a predominantly slow (35:65%) twitch muscle. Two
separate studies were performed on six subjects without (BR) and six with resistive vibration
exercise (RVE) countermeasures, respectively. Both VL and SOL underwent in BR decre-
ments of 15% in cross-sectional area and of 22% in maximal torque that were prevented
by RVE. Myosin heavy chain distribution showed increased type I and decreased type IIA in
BR both in VL and in SOL, the opposite with RVE. A substantial downregulation of proteins
involved in aerobic metabolism characterized both in SOL and VL in BR. RVE reversed the
pattern more in VL than in SOL, whereas proteins involved in anaerobic glycolysis were
upregulated. Proteins from the Z-disk region and from costamers were differently dysregu-
lated during bed rest (both BR and RVE), particularly in VL.
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1 Introduction
Bed rest, with or without a 61 head down tilt, is an appro-
priate model for eliminating the weight-bearing function in
man and a widely accepted space flight analog procedure for
human research whereby the pull of gravity is not
suppressed but shifted by 901 [1]. It has been adopted
for the studies of respiratory, cardiovascular, bone and,
particularly, muscle adaptive changes. With regard to the
latter tissue, bed rest is known to induce substantial atrophy
in lower limb muscles characterized by reduced cross-
sectional area (CSA) and fascicle length. Muscle mass
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decreases according to an approximately exponential func-
tion of time. This conclusion applies to several back and
limb muscles comprising the vastus lateralis (VL), a head of
the quadriceps, a mixed fast or type II/slow or type I
(50:50%) and the calf soleus (SOL), a predominantly slow
(35:65%) twitch muscle. The decrease in muscle mass
appears to attain an asymptote after 6–9 months at 70% of
the control level [2–8]. Muscle atrophy is accompanied by a
loss of maximum torque, the decrease of which is greater
than that in muscle CSA [9–11], likely a consequence of
decreased myofibrillar density [12–13]. The same trend
applies to the development of maximum instantaneous
(‘‘peak’’) power by lower limbs [14]. With regard to fiber size
and mechanical properties, peak force (Po) and peak short-
ening velocity (Vo) were found to vary in chemically skinned
type I SOL fibers as a function of bed rest duration [3, 6, 10,
15]. There appears to be agreement on a fiber diameter
decrement, decreased Po per CSA unit, and increased or
constant Vo, compensating for peak power development.
With regard to contractile proteins, after 37 days of bed rest,
myosin heavy chain (MyHC) bands were characterized by
38% weaker staining on SDS-PAGE, indicating that the
muscle fibers myosin content decreases in response to
unloading. In addition, electrophoretic protein analysis of
single fiber segments of the quadriceps muscle indicates
that MyHC, C-protein and actin, decreases in the same
proportion in response to 37 days of bed rest with only a
change in the isoform distribution of the regulatory myosin
light chains (MyLC) [10].
As is well known, the loss of muscle mass during BR is
brought about by a perturbed anabolic (synthesis)-catabolic
(breakdown) protein balance leading to a loss of muscle
nitrogen. The primary adaptive response appears to be a
decrease in protein synthesis [16–19] without any increased
breakdown of myofibrillar proteins by proteolytic enzymes
and/or by activation of the ubiquitin–proteasome pathway
[20–23]. Recent study has shed light also on circuits
controlling skeletal muscle hypertrophy such as IGF-1/
PI3K/AKT/mTOR signalling pathway known to promote
protein synthesis and on the control of protein degradation
and expression of ‘‘atrogens’’ [24, 25]. This was the
case also for the role of the transcriptional coactivator,
peroxisome proliferator-activated receptor g coactivator-1a
(PGC-1a), a master regulator of mitochondrial biogenesis
and atrogens program that is induced in response to
exercise [26–28].
The recent progress in muscle proteomics [29–33],
particularly the development of differential analysis, allows
to study structural, contractile, metabolic, stress response
and transport proteins modulation thereby providing a
powerful tool also for the study of functional adaptation of
muscle to bed rest. Thus, in view of future comparative
studies on the astronaut, it appeared of paramount impor-
tance to analyze the protein signature of lower limbs muscle
adaptation during bed rest without and with exercise
countermeasures [7, 34].
The aims of the present investigation are as follows:
(i) To analyze differentially, individually and in triplicate,
the muscle proteome of the VL and of the SOL
muscle before and after 55 days of horizontal bed rest
without (BR) and with resistive vibration exercise
(RVE) countermeasures. Preliminary structural and
ultrastructural data of muscle mass and maximum
torque as well as of fiber type distribution for the
investigated subjects were obtained from the experi-
mental protocol of a previous study by some of the
authors [35].
(ii) To quantitatively assess in individual samples the levels
of transcriptional coactivator PGC-1a known to increase
mitochondrial biogenesis in response to training and to
promote fiber-type switching from glycolytic toward
more oxidative fibers, in the two investigated muscles
and the relationship of its expression with proteome
changes.
(iii) To identify possible associations of the observed protein
changes with some biological key networks by Inge-
nuity Pathway Analysis (IPA).
2 Materials and methods
2.1 Subjects
In total, 12 subjects participating in the 55-day bed rest
study organized during the period 2003–2004 by the
European Space Agency (ESA) and the Centre of
Space Medicine Berlin at the Charite` University Medicine
Berlin, Berlin (Germany) were selected for this study. The
candidates were randomly assigned to two groups of six
subjects, the BR one and the one undergoing bed rest with
countermeasures (RVE) (Table 1). The caloric intake of the
subjects was controlled in order to maintain the body mass
relatively constant. Nutritional supervision was assured on
recommendation of the German Society of Nutrition. All
subjects gave their informed consent and the study was
approved by the ethical committee of the collaborating
institutions.
Table 1. Physical and physiological characteristics of the investi-
gated subjects (mean7SD)
Subjects BR (six) RVE (six)
Age (years) 32.777.2 33.276.1
Height (cm) 18276.5 187.277.2
Weight (kg) 75.675.5 82710.5
VO2max (mL kg
1 min1) 42.476.7 37.1710
BMI 22.672.8 24.172.3
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2.2 Muscle mass, structural and physiological
measurements
Left quadriceps mass and CSA were determined by
Magnetic Resonance Imaging. The mass of the right calf
muscle was obtained by Computed Tomography. Muscle
samples were taken on the second day of bed rest and close
to the end of the bed rest period (55th day) from the VL of
the left hip flexor/knee extensor quadriceps muscle, and
from the right calf SOL muscle (plantar flexor) according to
the method of Bergstrom [36]. Attempts were made to
extract the samples at approximately the same location in all
individuals.
2.3 Exercise measurements
Knee extensor and plantar flexor maximum torque levels were
determined on a force platform. RVE was carried out by means
of a vibrating foot platform (Galileo Space, Novotec, Pforz-
heim, Germany) feasible for a frequently repeated training
protocol throughout prolonged bed rest immobilization. The
subjects, in supine position, were attached to the device by
elastic belts with hips, shoulders and hands [37], and the
resting static force (Frest), depending on the two selected
protocols (morning or afternoon daily session), varied between
200 and 140% of the subjects’ body weight. Vibrations
(19–25Hz) were generated by means of eccentrical anti-phase
rotation of two masses under the feet on the opposite side of
the foot platform. Hence, each side of the platform accelerates
alternatively the left leg toward the head of the subject, whereas
the right leg is extending. The amplitude of the vibration being
preset, the acceleration increases with the vibration frequency
and so does the resistive-like force exerted by the extensor and
flexor muscles. The amplitude of the vibration results from the
acceleration of the platform and the resistive force of the leg
extension and was usually in the range of 0.5–1 cm. The
applied protocol consisted of two daily bouts (6min each) at
preset frequencies ranging from 19 at the beginning to 25Hz
toward the end of the bed rest period for a total of 89 sessions.
Four different exercise units were performed in each session
(squats, involving knee extensors; heel raises, activating foot
plantar flexors; toe raises, activating foot dorsi-flexors and kiks,
whereby knees were extended as quickly and forcefully as
possible). During each session, the above-mentioned exercise
units were carried out in ascending order. Thus, training
intensity was controlled by the resting force (Frest), vibration
frequency which increased throughout the bed rest period and
the duration of each exercise unit.
2.4 Muscle differential proteome profile
Muscle biopsies from VL and SOL from 12 healthy subjects
(males, age range 24–43 years) involved in the ‘‘Berlin Bed
Rest Study-1’’ (BBR-1) before and after 55 days of bed rest,
six without (BR) and six with countermeasures (RVE), were
analyzed by a quantitative 2-D DIGE protocol. The two sets
of samples were processed separately and at different times
as imposed by the availability of the material based on the
experimental protocol [35]. This implied the use of two
separate internal standards. 2-D DIGE methods and results
were obtained and inserted in an MIAPE-GE compliant
form [38] in Supporting Information Table 1S.
2.4.1 Protein extraction
Frozen muscles of each individual were ground in a frozen
mortar, suspended in sample buffer (7M urea, 2M thiourea,
4% CHAPS, 30mM Tris, 1mM PMSF) and solubilized by
sonication on ice. Proteins were selectively precipitated
using PlusOne 2D-Clean up kit (GE Healthcare) in order to
remove non-protein impurities, and re-suspended in lysis
buffer. The pH of the protein extracts was adjusted to 8.5 by
addition of 1M NaOH. Protein concentrations were deter-
mined by PlusOne 2D-Quant Kit (GE Healthcare).
2.4.2 CyDye labelling and experimental design
Protein minimal labelling with cyanine dyes (Cy3 and Cy5)
was performed, according to the manufacturer’s recommen-
dations, by mixing 50mg of individual sample extracts with
400pmol CyDye (CyDye DIGE Fluor minimal dye, GE
Healthcare) and incubating on ice in the dark for 30min. The
labelling reaction was quenched with 1mL L-lysine 10mM on
ice for 10min in the dark. Proteins extracted from each indi-
vidual muscle (VL and SOL) were labelled with Cy5. Internal
standards were generated by pooling individual samples before
and after bed rest from VL and SOL (BR and RVE) and were
Cy3 labelled. The inclusion of an internal standard improves
the matching of intra- and inter-gel images and allows
normalization across all gels [39]. The experimental design is
shown in Fig. 1. The ‘‘two dyes’’ protocol was adopted. Since a
double laser beam scanner was available, the analysis was
performed utilizing the combination of Cy3/Cy5, due to their
labelling efficiency and reliability compared with other dye
combinations as described previously [40–42]. No preferential
protein labelling or background noise were observed, and thus
a larger gel number was required compared with the three
dyes protocol. By utilizing the two dyes combination and the
manufacturer’s dye/protein ratio, no dye swap was needed
since all samples undergoing the statistical analysis were
labelled with the same dye (Cy5) and were normalized against
the same internal standard (Cy3 labelled).
2.4.3 2-D DIGE
Before isoelectric focusing, labelled samples were diluted in
an equal volume of 2 sample buffer containing 130mM
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DTT and 2% v/v IPG buffer (GE Healthcare). Samples
from each individual (40 mg) were combined with an
equal amount of internal standard, total protein loaded on
the gel was 80mg; rehydration buffer (7M urea, 2M
thiourea, 2% CHAPS, 65mM DTT, 0.5% IPG buffer pH
3.5–9.5 and BBF in traces) was added to a final
volume of 450 mL. Samples were separated on 24 cm, 3–10
nonlinear pH gradient IPG strips, with a voltage gradient
ranging from 200 to 8000V, for a total of 70 000VhT,
using an IPGphor electrophoresis unit (GE Healthcare).
Each individual sample was run in triplicate to minimize
the inter-gel variability and to increase the reliability
of the results. After focusing, IPG strips were equilibrated in
an SDS-reducing buffer (6M urea, 2% SDS, 20%
glycerol, 375mM Tris-HCl pH 8,8, 65mM DTT) for 15min,
then alkylated for 8min in the same buffer containing
135mM iodoacetamide instead of DTT. The second
dimension was carried out in 20 25 cm2, 12% T, 2.5% C
constant concentration polyacrylamide gels at 201C and
15mA per gel using the Ettan Dalt II system (GE Health-
care).
2.4.4 Image acquisition and gel analysis
CyDye-labelled gels were visualized and acquired using a
Typhoon 9200 Imager (GE Healthcare). Excitation and
emission wave lengths were chosen according to the
manufacturer’s recommendations (Cy3, Ex5 532 nm,
Em5 580 nm BP 30; Cy5, Ex5 633 nm, Em5 670 nm BP
30). Resolution was of 100 mm and the photomultiplier
voltage set to a level where the most abundant spots were
slightly beneath saturation. Image analysis was performed
using the DeCyder version 6.5 software (GE Healthcare). All
gel images were imported into individual DIA (differential
in-gel analysis) workspaces. Using the Batch Processor tool,
automated detection of protein spots was performed with
the following filter settings: estimated number of spots5
10 000, exclusion slope 41.2, minimal area cut-off o200
and peak height o144100 000. DIA workspaces were then
manually edited to eliminate gel artefacts (e.g. plate scrat-
ches and dust specks) and to re-include any incorrectly
excluded spot. The resulting spot maps (containing the spot
identifiers, locations and normalized volumes for all protein
Figure 1. 2-D DIGE experimental design. Protein extracts from VL and SOL of 12 healthy subjects (males, age range 24–43 years) enrolled
in the ‘‘Berlin Bed Rest Study-1’’ before and after 55 days of bed rest, six BR and six with RVE countermeasures were analyzed using a
quantitative 2-D DIGE protocol. Proteins extracted from each individual sample were labelled with Cy5. Internal standards were generated
by combining 50mg of protein from each individual samples (BR and RVE) of VL and SOL and labelled with Cy3. The internal standard was
co-separated with the sample to normalize quantitation across gels. Four different analyses were performed: (A) VL post- versus pre-BR;
(B) SOL post- versus pre-BR; (C) VL post- versus pre-RVE; (D) SOL post- versus pre-RVE.
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spots in each channel of each gel) were further processed in
the biological variation analysis (BVA) module. Individual
DIA workspaces for all analytical gels were imported into
the BVA module. The BVA workspace was used for inter-gel
protein spot matching. Detailed DIA and BVA information
are summarized in Supporting Information Table 2S.
Statistical analysis was performed using DeCyder EDA
module version 1.0 (Extended Data Analysis). Protein filters
were set to select only those protein spots that matched at
least on 90% of the gel images, and these protein spots were
included in data analysis. The paired Student’s t-test
(po0.05) was used to determine the protein spots that were
significantly different between analyses. The paired test can
be used because each data point in a group corresponds to a
matching data point in a other group. To minimize inclu-
sion of false-positive protein spot changes, protein expres-
sion data were filtered by the following criteria: paired
Student’s t-test (po0.05), 1.15-fold difference in abundance
and false discovery rate. The change of 1.15-fold and above
in protein abundance was considered for the present
analysis, taking into account the power of the DIGE method
to detect reliable difference in protein abundance down to
15% [43, 44]. False discovery rate correction was applied as
multiple testing correction method to keep the overall error
rate as low as possible [45]. Proteins of interest were iden-
tified by MALDI-ToF MS/MS or HPLC ESI MS/MS.
Differential results were validated for a selected number of
proteins by Western blotting (Supporting Information Figs.
1S and 2S) on the samples previously analyzed by 2-D
DIGE.
2.4.5 Protein identification by MALDI ToF MS/MS
and HPLC ESI MS/MS
In order to provide a proper amount of peptides for MS
analysis, semi-preparative gels, containing 400 mg of total
protein extract per strip, were loaded; electrophoretic
conditions were the same as for 2-D DIGE, except that gels
were stained with a protein fluorescent stain, as recom-
mended by manufacturer (Deep Purple Total Protein Stain,
5mL/L, GE Healthcare). Images acquisition was performed
using Typhoon 9200 laser scanner. Protein identification
methods are provided below and in a MIAPE-MS compliant
form in Supporting Information Table 1S [38]. Spots of
interest were excised from gel using the Ettan spot picker
robotic system (GE Healthcare), destained in 50% metha-
nol/50mM ammonium bicarbonate and incubated with
30mL of 4 ng/mL trypsin (Promega) dissolved in 10mM
ammonium bicarbonate for 16 h at 371C. Released peptides
were subjected to reverse-phase chromatography (Zip-Tip
C18 micro, Millipore), eluted with 50% ACN/1% formic
acid. Briefly, 1mL of peptides mixture was spotted onto the
sample plate of an Ultraflex III MALDI-ToF/ToF (Bruker
Daltonics) mass spectrometer; an equal volume of 10mg/
mL CHCA matrix dissolved in 70% ACN/30% 50mM citric
acid was applied and spots were air dried at room
temperature. MS proceeded at an accelerating voltage of
25 kV and spectra were externally calibrated using Peptide
Calibration Standard mixture (Bruker Daltonics); 1000 laser
shots were taken per spectrum. Proteins were identified by
comparing the digest peaks with a computer-generated
database of tryptic peptides from known proteins using
MASCOT, which utilizes a robust probabilistic scoring
algorithm. Search was carried out by correlation of unin-
terpreted spectra to Homo sapiens entries in NCBInr Data-
base. With regard to MASCOT parameters, one missed
cleavage per peptide was allowed and carbamidomethylation,
as fixed modification, and methionine oxidation, as variable
modification, were set. Peptide mass tolerance was set at
30 ppm. In cases where this approach was unsuccessful,
additional searches were performed using ESI-MS/MS.
Tandem electrospray mass spectra were recorded using a
Q-TOF mass spectrometer (Waters, Manchester, UK)
interfaced to a Waters CapLC capillary chromatograph.
Samples were dissolved in 0.1% aqueous formic acid,
injected onto a 300 mm 15mm Pepmap C18 column (LC
Packings, Amsterdam, The Netherlands), and eluted with
an ACN/0.1% formic acid gradient. The capillary voltage
was set to 3500V. A survey scan over the m/z range of
400–1300 was used to identify protonated peptides with
charge states of 2, 3 or 4, automatically selected for data-
dependent MS/MS analysis, and fragmented by collision
with argon. Signal-to-noise threshold value was set to 5. The
resulting product ion spectra were transformed onto a singly
charged m/z axis using a maximum entropy method
(MaxEnt3, Waters), and the proteins were identified by
correlation with uninterpreted spectra to entries in Swiss-
Prot/TrEMBL, using ProteinLynx Global Server (Version
1.1, Waters). The database was created by merging the
FASTA format files of Swiss-Prot, TrEMBL and their asso-
ciated splice variants. No taxonomic, or protein mass, and pI
constraints were applied. One missed cleavage per peptide
was allowed, and the fragment ion mass tolerance window
was set to 100 ppm. When identification was based on a
single-matching peptide, the sequences were confirmed by
manual sequencing using the MassLynx program PepSeq
(Waters). Measured parent and fragment masses were
typically within 0.03Da of their calculated values.
2.4.6 MyHC isoform composition
SDS electrophoresis was performed on muscle extracts
using a discontinuous buffer system with a 4% stacking gel
(pH 6.8) and 37% glycerol, 6% T constant concentration
running gel (pH 8.8) [46]. Samples were separated at 100V,
overnight. Gels were stained with SYPRO Orange (Mole-
cular Probe) and scanned using a 570 nm emission filter on
Typhoon 9200 Imager (GE Healthcare). Protein band
quantification was achieved using Image Quant software
(Molecular Dynamics); for each lane, MyHC bands were
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normalized against the total MyHC content. Individual
samples (1 mg) were run in triplicate. Molecular weight
markers containing MyHC from rabbit (212 kDa) and
bovine a2-macroglobulin (170 kDa) were run in a separate
lane. Differences between controls and bed rest without and
with countermeasures were computed by Student’s t-test,
the significance level being set at po0.01. A two-tailed F-test
was applied in order to verify the homoscedasticity of
variances. MyHC isoforms were gel excised and hydrolyzed
by trypsin, as previously described, after reduction and
alkylation of cysteine residues by 10mM DTT (100mL,
45min at 561C) and 55mM iodoacetamide (100mL, 30min
at room temperature in the dark), respectively. Proteins
were identified by ESI-MS/MS.
2.4.7 MyLC isoform distribution
To semi-quantitate the MyLC isoforms distribution typical
of slow and fast fibers, 50mg of labelled protein extracts were
separated in a 4.5–5.5 pH gradient in the first dimension,
and the second dimension was performed as indicated
above. Gel images were acquired by laser scanner and
quantitated by DeCyder as described previously.
2.4.8 Immunoblotting
Protein extracts (50 mg), from samples analyzed by 2-D
DIGE, were resolved by SDS-PAGE in triplicate and trans-
ferred at 300mA for 180min to PVDF membranes utilizing
a Transblot Cell (GE Healthcare). The membranes were
blocked in TBS (20mM Tris, 137mM NaCl, 0.1% Tween,
pH 7.5) containing 5% fat-free milk powder. The
membranes were incubated with antibodies diluted as
follows: polyclonal anti-PGC-1a, 1:1000 as primary antibody
(Santa Cruz Biotechnology, sc-13067, 200 mg/mL) and
1:10 000 peroxidase conjugate anti-rabbit as secondary anti-
body (GE Healthcare, NA934). Signals were visualized by
chemiluminescence by ECL plus (GE Healthcare). The
images were scanned and each band was quantitated using
ImageQuant Software (GE Healthcare). The data were
normalized against the total amount of proteins stained by
Sypro Ruby and subjected to a Student’s t-test and differ-
ences were considered significant at po0.05.
2.4.9 Bioinformatic data analysis
To examine and visualize ‘‘canonical pathways’’ of proteins
regulated by the long immobilization without (BR) and with
RVE countermeasures, the data were analyzed by using the
IPA system (Ingenuitys Systems, www.ingenuity.com).
This program uses a knowledge database derived from the
literature to relate gene products (e.g. genes, mRNAs and
proteins) based on their interactions and function. The
Swiss-Prot accession numbers of differentially expressed
proteins in VL and SOL after bed rest without and with RVE
countermeasures were tabulated in Microsoft Excel and
inserted into the program. Proteins matched to the corre-
sponding gene objects in the Ingenuity Pathways Knowl-
edge Base were named ‘‘focus proteins’’. The latter were
then used as starting points through the database for
interactions with other proteins stored in the database in
order to generate ‘‘canonical pathways’’. The significance of
the association between the data set and the ‘‘canonical
pathways’’ was measured by calculating either: (i) the ratio
of the number of proteins from the data set that map to the
pathway with respect to the total number of proteins
mapping to the ‘‘canonical pathway’’; (ii) the Fischer’s exact
test p-value (po0.05) determining the probability that the
association between the proteins in the data set and the
‘‘canonical pathway’’ was explained by chance only.
3 Results
3.1 Physical and physiological characteristics of the
subjects
The body mass of the subjects was essentially unchanged
throughout the experiment. Maximum aerobic power could
not be measured at the end of bed rest to avoid interference
with the results of most concurrent programmed measure-
ments. From the literature data, it appears that the conse-
quences of 50–60 days of bed rest on VO2 max are on the
order of 20% [47].
During bed rest, the CSA of both VL and SOL underwent
in BR conditions a decrement of 15%. Maximum torque of
both knee extensor and plantar flexor muscle groups
decreased by 22% [35]. Reduction of CSA and maximum
torque was almost entirely prevented by RVE in both the
investigated muscles. Fiber-type distribution was assessed
pre- and post-55 days of bed rest by image scans after
specific staining on cryosections [35]. No significant changes
were detected after BR in VL, whereas RVE induced a
significant (po0.05) shift from type I to type II. As for the
SOL, a slight non significant shift of fiber types I–II was
observed in BR that did not occur after RVE.
3.2 MyHC isoform composition of SOL and VL
muscles after 55 days of bed rest with and
without RVE countermeasures
In order to characterize muscles according to their MyHC
isoforms’ distribution, the latter not detectable by 2-D, SDS
gel analysis and semi-quantitative assessment (po0.01)
were carried out in both muscles before and after 55 days
bed rest, without and with RVE countermeasures. The
results are shown in Fig. 2. In VL after BR, an increment of
type I (15%) and of type IIX (17%), and a decrement of
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type IIA (12%) isoforms were shown. Adopting RVE
countermeasures induced a decrement of type I isoforms
(9%) and an increment of isoforms type IIA (18%),
whereas the switch to type IIX was absent. Isoform
composition of SOL appeared even more affected by bed rest
both without and with RVE countermeasures, bed rest being
characterized by an increment of type I (112%) isoforms
and by a decrement of type IIA isoforms (12%), whereas
type IIX was not statistically changed. Countermeasures
induced a marked decrement of type I isoforms (11%) and
an increment of type IIA isoforms (111%). No changes
were found for type IIX isoforms, as was the case for the VL.
Detailed MS data of MyHC isoforms are summarized in
Supporting Information Table 3S.
3.3 Detection and identification of proteins
differentially expressed in the VL and the SOL
muscles before and after bed rest
MyHC isoforms’ distribution provides direct information on
adjustments of contractile properties, and, indirectly, on
metabolic adaptations. To define the relationship between
the MyHC isoforms changes and the possible alteration of
metabolic and regulatory proteins occurring in this peculiar
model of immobilization, a comparative proteome analysis
is required. To this purpose, a 2-D DIGE strategy was
applied. Figure 3A shows a representative individual 2-D
map of skeletal muscle proteome. Spots found differentially
changed by in-gel differential analyses (post- versus
pre-BR and post- versus pre-RVE) are indicated by spot
numbers.
In VL muscle, 57 common spots were differentially
expressed in each investigated subject (post- versus pre-BR, t-
test: po0.05), of which, 33 were identified by MS. For each
spot, the statistical analysis (average ratio and p-values), the
protein accession number, together with the molecular
mass and pI, are listed in Table 2. Detailed MS data are
summarized in Supporting Information Table 4S and
shown in Supporting Information Fig. 3S. Among meta-
bolic proteins, two isoforms of glycogen phosphorylase
(muscle form) and of a-enolase were increased, suggesting
an increment of the anaerobic metabolism. A decrement of
mitochondrial proteins such as dihydrolipoil dehy-
drogenase, succinyl-CoA ligase, aconitate hydratase (three
isoforms) and ubiquinol–cytochrome c reductase complex
core protein I indicate a decrement of aerobic metabolism.
Whereas galectin-1, a protein involved in cell cycle, and two
isoforms of elongation factor 2 increase. The majority of
transport carrier proteins were significantly reduced (apoli-
poprotein A-1 precursor, two isoforms of serum albumin
and serotransferrin) with the exception of the voltage-
dependent anion-selective channel protein 1 and myoglobin
which were increased. Some proteins related to stress
response were upregulated, whereas others were down-
regulated, suggesting a possible specific role of their
modulation. Peroxiredoxin-2, HSPs b-6 and b-1 were less
abundant, by contrast peroxiredoxin-6, peroxiredoxin-1,
protein DJ-1, HSP 90-b, 78 kDa glucose-regulated protein
and glutathione-S-transferase m 2 were more abundant.
Carbonic anhydrase 1 showed a strong downregulation,
whereas the specific muscle isoform of carbonic anhydrase 3
was increased. As for contractile and structural proteins,
WD repeat protein 1 (two isoforms) and vinculin were
higher. Phosphatidylethanolamine-binding protein 1 was
also more abundant.
With regard to the SOL, muscle differential analysis
(post- versus pre-BR) indicates 47 spots statistically changed
(po0.05) common to all subjects, 26 of them identified by
MS (Fig. 3A). For each spot, the statistical analysis (average
ratio and p-values), the protein accession numbers, together
with the molecular mass and pI, are listed in Table 3.
Detailed MS data are summarized in Supporting Informa-
tion Table 4S and shown in Supporting Information 3
Fig. 3S. Metabolic proteins were characterized by a slight
increment of glycolytic enzyme a-enolase and glycogenin-1,
accompanied by a marked decrement of proteins involved in
aerobic metabolism such as succinyl-CoA ligase, aconitate
hydratase (three isoforms), NADH dehydrogenase
iron–sulfur protein 3 and ubiquinol–cytochrome c reductase
complex core protein I. At variance with VL muscle, trans-
port proteins, such as three isoforms of serum albumin,
were markedly upregulated. Stress proteins showed larger
differences compared with VL muscle. A common increased
abundance was observed for peroxiredoxin-6 and 78 kDa
Figure 2. SDS-PAGE of protein extracts of VL and SOL before
(pre-) and after (post-) bed rest without (BR) and with (RVE)
exercise countermeasures. In total, 1 mg of proteins was loaded
per lane. Graphical representation of MyHC fiber type compo-
sition (%) in all bed rest groups. Protein band quantification was
performed by Image Quant (Molecular Dynamics) software.
Differences were computed by Student’s t-test, the significance
level being set at po0.01. A two-tailed F-test was applied in
order to verify the homoscedasticity of variances. Significant
differences are indicated by asterisks.
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glucose-related protein (two isoforms), whereas a decrement
of HSP b-1 was profiled. In addition, a peculiar increment of
proteins involved in mitochondrial ROS production such as
glutathione-S-transferase m 2, glutathione transferase o-1,
protein disulfide-isomerase A3 was observed. Significant
changes were found in structural and contractile proteins,
particularly, an increased abundance of gelsolin and vincu-
lin. The latter were accompanied by a decrement of Kelch
repeat and BTB domain-containing protein 10 (two
isoforms), actin g-enteric smooth muscle, actin a cardiac
muscle 1 and mitochondrial inner membrane protein (two
isoforms).
3.4 Effects of RVE countermeasures on protein
differential expression
In VL, RVE countermeasures applied during bed rest (post-
versus pre-RVE), induced ubiquitous individual changes in
30 spots, 26 of them identified by MS as shown and
summarized in Fig. 3A and Table 4. MS data are
summarized in Supporting Information Table 4S and
shown in Supporting Information in Fig. 3S. Increment of
metabolic proteins related to carbohydrate metabolism,
Krebs cycle, mitochondrial respiratory chain and lipid
metabolism was observed. Dihydrolipoil dehydrogenase, 3-
hydroxyisobutyrate dehydrogenase, 2-oxoglutarate dehy-
drogenase E1 component (four isoforms), aconitate hydra-
tase (two isoforms), ubiquinol–cytochrome c reductase
complex core protein 1, ATP synthase D chain, very long
chain-specific acyl-CoA dehydrogenase mitochondrial,
enoyl-CoA hydratase mitochondrial and 3,2-trans-enoyl-CoA
isomerase were increased. Stress-related proteins, thior-
edoxin-dependent peroxide reductase, 60 kDa HSP mito-
chondrial, protein disulfide-isomerase A3 and heat shock-
related 70 kDa protein 2 were more abundant, whereas HSP
b-1 decreased.
RVE countermeasures during bed rest induced in the
SOL of all subjects significant abundance changes in 50
spots, 41 of them identified by MS as shown and summar-
ized in Fig. 3A and Table 5. MS data are summarized in
Supporting Information Table 4S and shown in Supporting
Information Fig. 3S. As previously observed for SOL after
BR, an increment of proteins involved in carbohydrate,
gluconeogenesis and glucose metabolisms was observed.
Proteins such as glyceraldehyde-3-phosphate dehydrogenase
Figure 3. (A) Skeletal muscle protein profiling by 2-D DIGE. A representative individual 2-D pattern gel image of 40 mg of protein extract,
separated in a pH 3–10 non-linear IPG strip in the first dimension and SDS gel (12% T, 2.5% C) as the second dimension. The image was
acquired with a 532 nm laser beam and 580 nm emission filter. Automated image analysis by DeCyder software detected and matched
3000 protein spots in a single-gel image. Spots found differentially changed by in-gel differential analysis (post- versus pre-BR and post-
versus pre-RVE, from VL and SOL) are indicated by spot number and listed in Tables 2–5. (B) Close-up of isoforms distribution of alkali
MyLCs (MyLC1) slow (1sb) and fast (1f) and of myosin regulatory light chain 2 (MyLC2) slow (2s2, 2s1, 2s) and fast (2f2, 2f1, 2f) shown as
close-up insertion from larger 2-D gel. Briefly, 50 mg of labelled protein extracts from pre- and post-BR and pre- and post-RVE from both
muscles, VL and SOL, were separated in a pH 4.5–5.5 IPG strip in the first dimension and SDS gel (12% T, 2.5% C) in a second dimension.
Gel images were acquired by laser scanner and analyzed by DeCyder software.
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(two isoforms), a-enolase, b-enolase (four isoforms), glyco-
gen phosphorylase muscle form, fructose-bisphosphate
aldolase A, phosphoglucomutase-1, pyruvate kinase
isozymes M1/M2 (two isoforms) and triosephosphate
isomerase were upregulated. Low abundance of some key
enzymes of the respiratory chain was detected such as
prohibitin and ubiquinol–cytochrome c reductase complex
core protein 1. Proteins involved in cell cycle, such as
galectin-1 and in protein translation and synthesis, such as
elongation factor 2 were increased. The abundance of
proteins involved in ROS production showed a peculiar
behaviour most of them being upregulated such as HSP b-1,
heat shock cognate 71 kDa protein, heat shock-related
70 kDa protein 2, protein disulfide-isomerase and subunit
A3, T-complex protein 1 subunit b, whereas glutathione
transferase o-1 was decreased. Structural and contractile
proteins abundance assessment indicated a decrement of
MyLC1, actin g-enteric smooth muscle and a skeletal
muscle, LIM domain 3, whereas WD repeat protein 1 (two
isoforms), gelsolin, desmin, vinculin, tubulin a-1 chain,
mitochondrial inner membrane protein and troponin T fast
were increased. Transport proteins were also altered: serum
albumin and serotransferrin were increased, whereas fatty
acid-binding protein was decreased. As for carbonic anhy-
drase 3, both isoforms were more abundant and may play a
role in regulating the acid–base balance of the muscle and,
particularly, protect the fibrocell from oxidative damage [48].
3.5 MyLC in the VL and in the SOL without and with
RVE countermeasures
A detailed analysis of MyLC light chain isoforms was
performed in a narrow pH gradient, as first dimension, in
order to detect possible changes in distribution, particularly
of isoforms functionally relevant for force development,
such as the phosphorylatable acidic subunits. A gel close up
is shown in Fig. 3B. The isoforms were labelled according to
the literature as shown in the legend. Quantitative analysis
indicates that no changes in MyLC isoforms distribution
were induced by immobilization without (BR) and with RVE
countermeasures in VL. On the contrary, a decrement of the
non-phosphorylatable isoforms MyLC 1a and MyLC 2f was
observed in SOL after RVE countermeasures (data not
shown).
3.6 The role of PGC-1a in the muscle catabolic state
To gain insight into the relationship between protein abun-
dance and muscle energy balance, PGC-1a was assessed by
immunoblotting on muscle extracts before and after bed rest,
without and with RVE countermeasures. As shown in Fig. 4,
PGC-1a levels were not significantly influenced in either
condition in VL. In SOL, no changes were observed after BR,
whereas RVE induced a statistically significant increase.T
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3.7 A bioinformatic treatment of the results by IPA
In an attempt to get further insight into the functional
significance of the data, a bioinformatic analysis of the
differentially expressed proteins was carried out adopting
IPA. On the basis of the system criteria, 64 differently
abundant proteins were involved in the identified networks.
Five so-called ‘‘canonical pathways’’ were selected over the
significance threshold (log (p-value)5 1.3) (Fig. 5). These
were mitochondrial dysfunction which was over-represented
in both VL and SOL (without and with RVE counter-
measures); fatty acid metabolism, which was over-repre-
sented in VL; oxidative stress under Nrf2 control over-
represented in all categories, stress response over-repre-
sented both in VL and in SOL without and with RVE
countermeasures; aryl hydrocarbon receptor (AHR) signal-
ling which was over-represented in both VL and SOL with-
out RVE countermeasures; negative acute-phase response,
over-represented in all conditions. The analysis supports the
hypothesized ‘‘canonical pathways’’, introducing an over-
representation of the negative acute-phase response and
AHR signalling. In addition, it also provides evidence of a
substantial influence of RVE countermeasures, particularly
in SOL in BR.
4 Discussion
In this study, structural and functional changes combined
with proteome analysis enabled us to describe and explain
specific alterations in response to bed rest without and with
RVE countermeasures. Concerning proteomic analyses, it
should be pointed out that, due to the study design, BR and
RVE data are the outcome of two separate and independent
investigations. This procedure, depending on the adopted
statistical data treatment (paired Student’s t-test), limits
further potential information. This approach is novel in
human muscle research and presents several advantages over
previous investigations. In fact, this study: (i) is the first
proteomic characterization of two metabolically different
muscles in the same subject that are differently influenced by
bed rest; (ii) features changes induced by RVE counter-
measures in muscles with different fiber types composition.
Moreover, by analyzing the above-described results with
bioinformatic tools, it was possible to demonstrate the exis-
tence of bed rest-induced catabolic pathways, thereby shed-
ding light on the changes brought about by immobilization
and the strategy elicited by RVE to counteract the atrophic
process in healthy male subjects. A gene expression profile
analysis yielding a list of perturbed genes grouped in mole-
cular networks and biological processes has been recently
obtained for the same muscles in females during 60 days of
Figure 5. Altered functions in VL and SOL
during bed rest without and with RVE coun-
termeasure identified by IPA software. The
functional groups are displayed along the
x-axis. The y-axis displays the log-
(significance) of the functional groups.
Functions are listed from the most significant
to the least significant ones and the black line
indicates the threshold of significance
(p5 0.05).
Figure 4. PGC-1a quantitation by immunoblotting. Protein
extract (50mg), from the individual samples analyzed by 2-D
DIGE, was separated in 6% SDS-PAGE gel and electrotransferred
to PVDF membrane. A polyclonal anti-PGC-1a (1:1000 dilution)
and an anti-rabbit peroxidase conjugate (1:10 000) antibodies
were utilized. The signals were revealed by ECL Plus. The
histogram represents the mean values for volumes calculated
for each detected band using the ImageQuant Software. Differ-
ences were computed by Student’s t-test, the significance level
being set at po0.05. Significant differences are indicated by
asterisks.
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bed rest without and with exercise countermeasures and/or
dietary protein supplementation (WISE study 2005) [49].
4.1 Morphometric parameters
Body mass and physical performance parameters of the
investigated subjects are in agreement with those observed
in the previous bed rest studies. The observed reduction of
muscle cross section after 55 days of BR is well within the
range of the literature data for both quadriceps and calf
muscle after a comparable period of BR immobilization.
The corresponding decrease of knee extensor and plantar
flexor maximum torque, respectively, is also within the
range of the values found by others in comparable experi-
mental conditions [50], (Ferretti 2009, personal commu-
nication). For a functional evaluation of the investigated
muscles, it was assumed that the above figures would apply
uniformly to each of the VL heads and to the whole SOL,
respectively. In any case, it is worth noting that our
findings are characterized by a high inter-individual varia-
bility. RVE countermeasures, according to the protocol
adopted for this study whereby the subject underwent acti-
vation of both type I (aerobic) and type IIA and IIX (fast
oxidative and glycolytic) fibers, were very effective in
protecting average CSA and maximum torque of both VL
and SOL muscles. The exercise metabolic load imposed by
the RVE protocol can be inferred by the relatively high blood
lactate levels (7–9mM) incurred by the subjects after all-out
squats exercise bouts of only 6min duration throughout
bed rest [37].
4.2 Fiber type switching during bed rest without
and with countermeasures
In order to precisely profile MyHC distribution in VL and
SOL, an electrophoretic technique suitable to detect fine
adjustments evaluating semi-quantitatively, the various
fractions of type I, IIA, IIX isoforms was adopted. The
pattern of MyHC distribution (Fig. 2) appears to be affected
by BR in both VL and SOL. MyHC IIA fibers, i.e. those
characterized by both oxidative and glycolytic metabolism
were particularly affected. In VL, this fiber fraction was
partially split into slow oxidative type I and pure fast
glycolytic type IIX fibers. RVE countermeasures were
effective in counteracting this switch by lowering type I
MyHC fraction thereby increasing the fibers with mixed
phenotype, whereas MyHC IIX isoforms were unchanged. A
postural muscle such as SOL, known to be largely influ-
enced by BR, underwent a switch toward oxidative metabo-
lism by RVE countermeasures featuring an increment of the
mixed phenotype. The results obtained by electrophoresis of
MyHC proteins are supported by immunohistochemical
MyHC expression profiles previously reported from the
same bed rest study [35]. Fiber type functional changes,
particularly decrease of Po and increase of Vo were described
in humans after immobilization [13]. In a previous human
muscle proteomic study of ageing [31], we suggested a
possible dependence of muscle Po and Vo on the level of
acidic phosphorylatable isoforms fast (f) of MyLC. As shown
in Fig. 3B, this correlation does not seem to occur during
BR, a condition characterized by the absence of changes in
MyLC phosphorylatable isoform distribution. With regard to
metabolic proteins, during BR, there appears to be a
progressive impairment of the oxidative pathway which,
both in VL and in SOL, is partially prevented by the adopted
protocol of RVE countermeasures. It appears that even very
short lasting exercise bouts as those imposed by the present
protocol can be very effective, provided an increase in
aerobic metabolic rate above the anaerobic threshold is
elicited together with a consistent accumulation of lactate in
the exercised muscles, particularly in VL.
On the other hand, the relationships between the level of
PGC-1a, the master regulator of mitochondrial biogenesis,
atrogens program and of the metabolic changes character-
izing a loss of muscle mass, occur particularly in
SOL with RVE countermeasures. PGC-1a parallels in
SOL after RVE the observed changes in MyHC isoforms’
distribution and the upregulation in aerobic metabolism
profiled by 2-D DIGE by way of increased mitochondrial
activity.
4.3 Structural protein changes
Molecular changes occurring in the investigated muscles
during bed rest at the structural level involving contractile
proteins seem to be dominated by the mechanical stress
imposed by muscle unloading and reloading without and
with RVE countermeasures. A peculiar signature of
mechanical stress sensors is profiled by the present
proteome analysis. Indeed, some of the contractile proteins
involved in mechanical stress [51] were deregulated, parti-
cularly in VL with RVE countermeasures. The above chan-
ges involve MyHCs, cardiac and skeletal actins, troponin
subunits, LIM domain and myozenin. This functional
impairment could profoundly influence the calcium-acti-
vated signalling process associated with the Z-disk function.
It is known that the above mechanism involves molecules
such as LIM domain proteins, PDZ-LIM domain proteins,
myozenin gene family members, titin-associated ankyrin
repeat family proteins, as well as muscle-specific ring finger
proteins, which have been identified as potential molecular
mechanical sensor components. An unequivocally signifi-
cant role of calcium signalling is played by myozenin which
was identified in skeletal muscle as a filamin-, actinin- and
telethonin-binding protein at the Z-disk [52]. Among others,
the organization of the thin filament also appears to be
influenced by BR: the end-capping protein gelsolin
increased during BR, whereas troponin T was found to be
less abundant, suggesting that the single regulatory units of
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the thin filament were also perturbed [53]. RVE counter-
measures appear to counteract this alteration by increasing
troponin T and gelsolin. The disruption of the sarcomeric
organization could also be the consequence of a loss of titin,
as observed in animal models [54] that was not detectable by
the present analysis.
Mechanical stress sensors are not limited to the Z-disk
region. They are also embedded in muscle-specific
membrane systems such as the costamere, intercalated
disks and caveolae-like microdomains (vinculin, desmin and
WD repeat). The present analysis confirms that such
modulation of muscle functions requires an integrated
analysis to determine the molecular events profiling func-
tional changes. In any case, the stressor elements are
induced by RVE that appear to positively counteract the loss
of sarcomeric organization found after BR.
4.4 Mitochondrial dysfunction
Mitochondria contain a series of redox carriers transferring
single electrons to oxygen. Conditions of both lack of O2 or
hyperoxia but also bed rest, particularly when adopting RVE
countermeasures [55], result in the generation of an excess
of ROS particularly, superoxide. Mitochondria also contain
an extensive antioxidant defense against ROS, which would
otherwise cause oxidative damage to cellular components.
This condition appears to occur during muscle inactivity
such as during bed rest, particularly in the presence of RVE
countermeasures.
Strictly related to mitochondrial defense is the dysregula-
tion of a number of stress–response molecules such as e.g.
glutathione-S-transferase m 2, HSP 90-b, peroxiredoxin-1,
glutathione-S-transferase o 2, superoxide dismutase
[Cu-Zn], actin g-enteric smooth muscle, actin a cardiac muscle
1 and actin a skeletal muscle. These changes are under Nrf2
control. Nrf2 activates the antioxidant machinery and
suppresses proinflammatory pathways mediated by NF-kB
signalling [56]. The overexpression of this set of molecules
indicates that BR is a stressful condition and induces changes,
leading to a loss of muscle mass and function. RVE appears to
counteract these events only partially, and it is difficult to
assess if the adopted protocol aimed at counteracting muscle
loss is the most appropriate to restore muscle function. In this
context, it is noteworthy that carbonic anhydrase 1, which is
inhibited by nitric oxide signals [57], remains strongly down-
regulated at least in VL, a finding that could indirectly reflect
iNOS induction. Heat shock factor 1, which is essential for
protecting cells from protein-damage associated with misfol-
ded proteins and which regulates the insulin-signaling path-
way during aging [58], is also less abundant following BR and
was even not restored to a physiological level in VL with RVE
countermeasures. On the whole, the present findings, there-
fore, indicate a series of candidate molecules able to monitor
and profile the effects of unloading and exercise counter-
measure protocols in human skeletal muscles.
4.5 AHR signalling
The bioinformatic (IPA) approach also indicates activation
of the AHR. The latter is a cytosolic protein associated with
chaperone and immunophilin-like proteins (such as
HSP90). Upon ligand activation, AHR dissociates from the
complex, translocates into the nucleus and recruits several
molecules for its further activation. This AHR complex
induces transcriptional activation of genes encoding xeno-
biotic metabolizing enzymes (GST, NADPH-quinone
oxidoreductase and UDP-glucuronyl-S-transferase) and
other growth factors and proteins, involved in cell-cycle
progression and apoptosis. These events could be mediated
by calcium-activated signaling, in particular via calcineurin
whose modulation induces nuclear transcription. The
induction of metabolic enzymes and, possibly, of post-
transductional modifications directly and indirectly observed
during BR shall put forward new hypotheses on the events
related to BR-induced muscle waste and on the efficacy of
exercise countermeasures.
4.6 Negative acute-response phase
With regard to the negative acute-response phase mediated
by NF-kB signalling, the activation of this pathway supports
the possible role of a mechanical stress response. The acti-
vation of this pathway, actually, is currently detected in
muscle proteomic studies, particularly under pathological
conditions [59]. Further investigation with different bed rest
protocols is required to validate the present findings on
unloaded and reloaded muscles.
4.7 Conclusions
Differential protein profiling during bed rest, particularly
the study of muscle proteome changes attributable to exer-
cise countermeasures, has proven to be an invaluable tool
for the analysis of structural as well as metabolic changes
occurring throughout lower limbs immobilization. It goes
without saying that a 55-day post- versus pre-exposure
comparison, as was the case for this study, does not allow to
detect the time course of either anabolic or catabolic muscle
protein balance. In fact, the latter is a biphasic process
whereby an early decrease of protein synthesis accompanied
by a downregulation of the pathways controlling muscle
hypertrophy precedes the tissue degradation phase. Despite
this limitation, the comparison of the metabolic dysregula-
tion induced in two anatomically and functionally different
muscles, such as the VL and the SOL, by vibration coun-
termeasures, such as those adopted for the present investi-
gation, provides unique information on both muscle protein
signature in the course of BR, opening new avenues on
protein variants as possible markers of rehabilitation and of
monitoring of RVE countermeasures. The present data also
Proteomics 2010, 10, 3756–3774 3771
& 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
provide evidence of changes induced in SOL by the trans-
criptional coactivator PGC-1a known to effect fiber type
switching from glycolytic toward oxidative. In addition, key
protein analyses at appropriate time intervals throughout
bed rest together with those monitoring the state of activa-
tion of metabolic pathways and of specific markers, parti-
cularly those related to mechanical stress and ROS control,
shall prove extremely useful for the evaluation of the func-
tional status of unloaded limb muscles throughout bed rest
without and with exercise countermeasures.
It should be pointed out that muscle proteome analysis
comprises (i) the characterization of all proteins expressed
by the tissue and (ii) possible differences in protein abun-
dance induced by physiological, paraphysiological and
patological variables. In healthy subjects, the first published
systematic characterization of the human VL muscle (by
2-DE-HPLC ESI-MS/MS) carried out in our laboratory dates
back to year 2003 [60]. In 2008, Hojlund et al. characterized
the same muscle by 1-D gel electrophoresis and HPLC ESI-
MS/MS, providing a larger data set of proteins [61]. Subse-
quently, Kovalyova et al. identified 89 proteins in human VL
by 2-DE and MALDI-ToF [62]. The above study is essentially
descriptive and does not address any specific aspect of
muscle function. More recently, Holloway et al. by using
iTRAQ and 2-DE coupled with LC MALDI MS/MS investi-
gated differential expression of metabolic and myofibrillar
proteins in response to interval exercise training [63].
In conclusion, muscle proteomic profiling as carried out in
healthy subjects during inactivity without and with exercise
countermeasures provides a precise description of the func-
tional status of the tissue. In addition, the analysis of the
characteristics of negative and positive stimuli, such as training
and detraining onmuscle function, as well as of those aimed at
post-traumatic rehabilitation or at the prevention of physiolo-
gical and pathological sarcopenia, such as in ageing or in
disease, could take advantage of the present approach.
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